Passage Bio, Inc.
PASG
$4.59
$0.020.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -37.68M | -45.52M | -45.26M | -56.86M | -63.46M |
| Total Depreciation and Amortization | 656.00K | 728.00K | 1.27M | 1.85M | 2.48M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.59M | 9.29M | 6.05M | 11.22M | 12.00M |
| Change in Net Operating Assets | 783.00K | 4.00M | 4.47M | 7.72M | 6.11M |
| Cash from Operations | -30.65M | -31.51M | -33.47M | -36.07M | -42.87M |
| Capital Expenditure | -- | -- | -14.00K | -34.00K | -34.00K |
| Sale of Property, Plant, and Equipment | 605.00K | 1.17M | 1.17M | 1.17M | 585.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 39.05M | 52.74M | 67.73M | 68.78M |
| Cash from Investing | 605.00K | 40.22M | 53.89M | 68.86M | 69.33M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.00K | 23.00K | 61.00K | 61.00K | 132.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23.00K | 23.00K | 61.00K | 61.00K | 132.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.02M | 8.73M | 20.48M | 32.86M | 26.58M |